These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2285838)

  • 21. Drug addiction as drive satisfaction ("antidrive") dysfunction.
    Kostowski W
    Acta Neurobiol Exp (Wars); 2002; 62(2):111-7. PubMed ID: 12201032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between anabolic androgenic steroids and muscle dysmorphia: a review.
    Rohman L
    Eat Disord; 2009; 17(3):187-99. PubMed ID: 19391018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mindfulness based interventions for addictive disorders: a review].
    Skanavi S; Laqueille X; Aubin HJ
    Encephale; 2011 Oct; 37(5):379-87. PubMed ID: 22032281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gilles de la Tourette's syndrome with and without obsessive-compulsive disorder compared with obsessive-compulsive disorder without tics: which symptoms discriminate?
    Cath DC; Spinhoven P; van Woerkom TC; van de Wetering BJ; Hoogduin CA; Landman AD; Roos RA; Rooijmans HG
    J Nerv Ment Dis; 2001 Apr; 189(4):219-28. PubMed ID: 11339317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repetitive movements and behaviors in neurological and psychiatric practice: Distinctions and similarities between Tourette disorder and obsessive-compulsive disorder.
    Hartmann A; Millet B
    Rev Neurol (Paris); 2018 Apr; 174(4):199-202. PubMed ID: 29606319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anhedonia in obsessive-compulsive disorder: beyond comorbid depression.
    Abramovitch A; Pizzagalli DA; Reuman L; Wilhelm S
    Psychiatry Res; 2014 May; 216(2):223-9. PubMed ID: 24564999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain reward systems and compulsive drug use.
    Kenny PJ
    Trends Pharmacol Sci; 2007 Mar; 28(3):135-41. PubMed ID: 17276521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonpharmacologic approaches to substance abuse treatment.
    Carroll KM; Schottenfeld R
    Med Clin North Am; 1997 Jul; 81(4):927-44. PubMed ID: 9222261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individuals with high obsessive-compulsive tendencies or undermined confidence rely more on external proxies to access their internal states.
    Zhang Z; Wang M; Miao X; Li Y; Hitchman G; Yuan Z
    J Behav Ther Exp Psychiatry; 2017 Mar; 54():263-269. PubMed ID: 27710870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
    Pigott TA; Pato MT; Bernstein SE; Grover GN; Hill JL; Tolliver TJ; Murphy DL
    Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-occurrence of obsessive-compulsive disorder and substance use disorder in the general population.
    Blom RM; Koeter M; van den Brink W; de Graaf R; Ten Have M; Denys D
    Addiction; 2011 Dec; 106(12):2178-85. PubMed ID: 21714825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between insight and control in obsessive-compulsive disorder: implications for the insanity defense.
    Rotter M; Goodman W
    Bull Am Acad Psychiatry Law; 1993; 21(2):245-52. PubMed ID: 8364240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive processing of drug-related stimuli: the role of memory and attention.
    Weinstein A; Cox WM
    J Psychopharmacol; 2006 Nov; 20(6):850-9. PubMed ID: 16401648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mood in relation to subclinical obsessive-compulsive symptoms.
    Spinella M
    Int J Neurosci; 2005 Apr; 115(4):433-43. PubMed ID: 15809213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compulsive buying.
    Lejoyeux M; Weinstein A
    Am J Drug Alcohol Abuse; 2010 Sep; 36(5):248-53. PubMed ID: 20560822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Addiction motivation reformulated: an affective processing model of negative reinforcement.
    Baker TB; Piper ME; McCarthy DE; Majeskie MR; Fiore MC
    Psychol Rev; 2004 Jan; 111(1):33-51. PubMed ID: 14756584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redefining addiction. I. Making addiction a scientifically and socially useful concept.
    Peele S
    Int J Health Serv; 1977; 7(1):103-24. PubMed ID: 832935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Travel to the land of shadows].
    Longerich B
    Krankenpfl Soins Infirm; 2015; 108(3):68-71. PubMed ID: 25946817
    [No Abstract]   [Full Text] [Related]  

  • 39. Clomipramine in obsessional disorders: a cautionary tale.
    Morstyn R
    Aust N Z J Psychiatry; 1988 Jun; 22(2):190-4. PubMed ID: 3401188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inpatient treatment of patients with severe obsessive-compulsive disorder.
    Calvocoressi L; McDougle CI; Wasylink S; Goodman WK; Trufan SJ; Price LH
    Hosp Community Psychiatry; 1993 Dec; 44(12):1150-4. PubMed ID: 8132187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.